{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:34:19Z","timestamp":1760574859764,"version":"build-2065373602"},"reference-count":28,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Radioactive seed migration after low-dose-rate brachytherapy (LDR-BT) for prostate cancer is a known phenomenon; however, its clinical impact remains unclear. We retrospectively analyzed 611 patients treated with LDR-BT using loose iodine-125 seeds. Post-treatment imaging was used to assess seed migration. Treatment efficacy was evaluated using post-plan dosimetry (V100 and D90) and biochemical recurrence-free survival (bRFS). Seed migration was observed in 150 patients (24.5%) within 1\u20133 months post-treatment, involving a total of 210 seeds. Migration sites included lungs, vasculature, and seminal vesicles. Hematogenous migration was significantly associated with higher seed counts. Seminal vesicle migration was linked to increased needle usage and absence of neoadjuvant hormone therapy. No significant differences were observed in V100, D90, or bRFS between patients with or without seed migration. However, migration of \u22653 seeds correlated with significantly lower V100 and with a trend toward decreased bRFS. Limited seed migration appears to have minimal clinical impact. However, \u22653 migrated seeds may reduce dosimetric quality and affect treatment efficacy. Risk factors include larger prostate volume as well as higher seed and needle counts. Improved planning and using linked seeds may reduce migration and improve outcomes in LDR-BT for prostate cancer.<\/jats:p>","DOI":"10.3390\/curroncol32100567","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T08:34:26Z","timestamp":1760517266000},"page":"567","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive Factors and Clinical Impact of Radioactive Seed Migration After Prostate Brachytherapy: A Retrospective Study"],"prefix":"10.3390","volume":"32","author":[{"given":"Shota","family":"Kikuchi","sequence":"first","affiliation":[{"name":"Department of Urology, School of Medicine, Showa Medical University, Tokyo 142-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0261-6303","authenticated-orcid":false,"given":"Takashi","family":"Fukagai","sequence":"additional","affiliation":[{"name":"Department of Urology, School of Medicine, Showa Medical University, Tokyo 142-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Yamatoya","sequence":"additional","affiliation":[{"name":"Department of Urology, School of Medicine, Showa Medical University, Tokyo 142-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Oshinomi","sequence":"additional","affiliation":[{"name":"Department of Urology, School of Medicine, Showa Medical University, Tokyo 142-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Nagata","sequence":"additional","affiliation":[{"name":"Department of Urology, School of Medicine, Showa Medical University, Tokyo 142-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1631-5010","authenticated-orcid":false,"given":"Masashi","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Urology, School of Medicine, Showa Medical University, Tokyo 142-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Toyofuku","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Department of Radiology, School of Medicine, Showa Medical University, Tokyo 142-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhito","family":"Sekimoto","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Department of Radiology, School of Medicine, Showa Medical University, Tokyo 142-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8272-5625","authenticated-orcid":false,"given":"Masako","family":"Kato","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Department of Radiology, School of Medicine, Showa Medical University, Tokyo 142-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madoka","family":"Morota","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Department of Radiology, School of Medicine, Showa Medical University, Tokyo 142-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Department of Radiology, School of Medicine, Showa Medical University, Tokyo 142-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000176019","article-title":"Health-related quality of life after radical prostatectomy and low-dose-rate brachytherapy for localized prostate cancer","volume":"82","author":"Wyler","year":"2009","journal-title":"Urol. Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1111\/j.1464-410X.2011.10827.x","article-title":"Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group","volume":"109","author":"Grimm","year":"2012","journal-title":"BJU. Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/iju.14098","article-title":"Low-dose-rate brachytherapy for prostate cancer: A 15-year experience in Japan","volume":"27","author":"Tanaka","year":"2020","journal-title":"Int. J. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"M\u00e4kel\u00e4, L., P\u00e9tas, A., Mikkola, A., and Visap\u00e4\u00e4, H. (2025). Long-term outcomes of LDR-brachytherapy for localized prostate cancer. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1326355"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41391-024-00817-z","article-title":"Low-dose-rate brachytherapy as a primary treatment for localised and locally advanced prostate cancer: A systematic review of economic evaluations","volume":"28","author":"Stanberry","year":"2025","journal-title":"Prostate. Cancer. Prostatic. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/jjco\/hyq118","article-title":"Swelling of the prostate gland by permanent brachytherapy may affect seed migration","volume":"40","author":"Kono","year":"2010","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.urology.2005.01.047","article-title":"Reduction of pulmonary migration of permanent interstitial sources in patients undergoing prostate brachytherapy","volume":"66","author":"Stone","year":"2005","journal-title":"Urology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0022-5347(05)64589-2","article-title":"Prostate brachytherapy seed migration to a coronary artery found during angiography","volume":"168","author":"Davis","year":"2002","journal-title":"J. Urol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0022-5347(05)67061-9","article-title":"Prostate brachytherapy seed migration to the right ventricle found at autopsy following acute cardiac dysrhythmia","volume":"164","author":"Davis","year":"2000","journal-title":"J. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/iju5.12707","article-title":"Prostate brachytherapy seed migration to the right renal artery due to right-to-left shunting across a patent foramen ovale","volume":"7","author":"Nakiri","year":"2024","journal-title":"IJU Case. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"673.e17","DOI":"10.1016\/j.urology.2006.03.056","article-title":"Cardiac and hepatic seed implant embolization after prostate brachytherapy","volume":"68","author":"Nguyen","year":"2006","journal-title":"Urology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0360-3016(95)00521-Y","article-title":"A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation","volume":"32","author":"Stock","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijrobp.2005.07.981","article-title":"Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and posttreatment biopsy results","volume":"64","author":"Stock","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brachy.2004.06.002","article-title":"Migration of implanted free radioactive seeds for adenocarcinoma of the prostate using a Mick applicator","volume":"3","author":"Kunos","year":"2004","journal-title":"Brachytherapy"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.canrad.2004.06.001","article-title":"Iodin 125 seed migration after prostate brachytherapy: A study of 170 patients","volume":"8","author":"Chauveinc","year":"2004","journal-title":"Cancer. Radiother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ijrobp.2003.10.050","article-title":"Radioactive seed migration to the chest after transperineal interstitial prostate brachytherapy: Extraprostatic seed placement correlates with migration","volume":"59","author":"Eshleman","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.brachy.2012.03.003","article-title":"Seed migration in prostate brachytherapy depends on experience and technique","volume":"11","author":"Taussky","year":"2012","journal-title":"Brachytherapy"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1748-717X-6-130","article-title":"Incidence of seed migration to the chest, abdomen, and pelvis after transperineal interstitial prostate brachytherapy with loose (125)I seeds","volume":"6","author":"Sugawara","year":"2011","journal-title":"Radiat. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s11604-016-0578-7","article-title":"The retrospective analysis of the relationship between prescribed dose and risk factor for seed migration in iodine-125 prostate brachytherapy","volume":"34","author":"Hirose","year":"2016","journal-title":"Jpn. J. Radiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13014-015-0532-3","article-title":"Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort study","volume":"10","author":"Nakano","year":"2015","journal-title":"Radiat. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.3390\/curroncol30040308","article-title":"Seed density as a new predictive index of seed migration in brachytherapy for prostate cancer using iodine-125 loose seed","volume":"30","author":"Yamaguchi","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.prnil.2017.09.003","article-title":"Late seed migration after prostate brachytherapy with Iod-125 permanent implants","volume":"6","author":"Maletzki","year":"2018","journal-title":"Prostate. Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.urology.2007.11.025","article-title":"Fate of seminal vesicles and prostate after medical castration: How long is the optimal duration of neoadjuvant treatment for prostate cancer before radiation?","volume":"72","author":"Furuya","year":"2008","journal-title":"Urology."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1118\/1.2409748","article-title":"Effects of seed migration on post-implant dosimetry of prostate brachytherapy","volume":"34","author":"Gao","year":"2007","journal-title":"Med. Phys."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11604-021-01189-3","article-title":"A review on permanent implants for prostate brachytherapy with comparison between stranded and loose seeds","volume":"40","author":"Wei","year":"2022","journal-title":"Jpn. J. Radiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.brachy.2006.08.004","article-title":"Prostate brachytherapy seed migration to the right coronary artery associated with an acute myocardial infarction","volume":"5","author":"Zhu","year":"2006","journal-title":"Brachytherapy"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/jjco\/hyn063","article-title":"Radiation pneumonitis caused by a migrated brachytherapy seed lodged in the lung","volume":"38","author":"Miura","year":"2008","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.brachy.2011.12.003","article-title":"Radioactive seed migration after transperineal interstitial prostate brachytherapy and associated development of small-cell lung cancer","volume":"11","author":"Chen","year":"2012","journal-title":"Brachytherapy"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/10\/567\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:42:35Z","timestamp":1760521355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/10\/567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":28,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["curroncol32100567"],"URL":"https:\/\/doi.org\/10.3390\/curroncol32100567","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,11]]}}}